EKF Diagnostics Holdings plc (EKF.L) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. EKF.L files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.53% | 30.00% | Pass |
| Interest-bearing investments | 12.52% | 30.00% | Pass |
| Non-permissible income | 0.51% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 3.41% | 33.00% | Pass |
| Interest-bearing investments | 16.87% | 33.00% | Pass |
| Non-liquid assets | 76.56% | at least 20.00% | Pass |
| Non-permissible income | 0.51% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 3.41% | 33.33% | Pass |
| Cash + interest-bearing securities | 16.87% | 33.33% | Pass |
| Accounts receivable | 23.44% | 33.33% | Pass |
| Non-permissible income | 0.51% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 3.41% | 33.33% | Pass |
| Cash + interest-bearing securities | 16.87% | 33.33% | Pass |
| Accounts receivable | 23.44% | 50.00% | Pass |
| Non-permissible income | 0.51% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.40% | 33.00% | Pass |
| Cash + interest-bearing securities | 11.84% | 33.00% | Pass |
| Accounts receivable | 4.61% | 33.00% | Pass |
| Non-permissible income | 0.51% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.30% | 33.00% | Pass |
| Cash + interest-bearing securities | 11.38% | 49.00% | Pass |
| Accounts receivable | 4.44% | 49.00% | Pass |
| Non-permissible income | 0.51% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.30% | 33.33% | Pass |
| Cash + interest-bearing securities | 11.38% | 33.33% | Pass |
| Accounts receivable | 15.82% | 49.00% | Pass |
| Non-permissible income | 0.51% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 48.00 | NEUTRAL |
| Stochastic %K (14) | 66.67 | NEUTRAL |
| CCI (20) | 45.00 | NEUTRAL |
| Williams %R (14) | -33.33 | NEUTRAL |
| MACD (12,26,9) | 0.05 | BUY |
| ROC (10) | -0.79 | SELL |
| Momentum (10) | -0.20 | SELL |
| EMA (10) | 25.29 | SELL |
| SMA (10) | 25.27 | SELL |
| EMA (20) | 25.30 | SELL |
| SMA (20) | 25.18 | BUY |
| EMA (30) | 25.36 | SELL |
| SMA (30) | 25.32 | SELL |
| EMA (50) | 25.48 | SELL |
| SMA (50) | 25.50 | SELL |
| EMA (100) | 25.64 | SELL |
| SMA (100) | 25.87 | SELL |
| EMA (200) | 25.87 | SELL |
| SMA (200) | 25.53 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Medical Devices
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab HbA1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test HbA1c, fully automated hemoglobin A1c analyzer for the monitoring and management of diabetes; and STAT-Site W Beta-Hydroxybutyrate analyzer. In addition, the company offers Creamatocrit Plus, a breast milk analyzer; QuPID and True20 pregnancy tests; Lactate Scout Vet, a handheld lactate analyzer for veterinary care; Hemo Vet, a point-of-care hemoglobin and hematocrit analyzer; Lactate Scout Sport, a lactate analyzer for sports performance; Biosen series for sports; and EKF Link, a data management solution that integrates point-of-care analyzers. Further, it offers Beta-Hydroxybutyrate LiquiColor for monitoring ketosis; RaPET, a range of immunoassay kits; QuStick Strep A for Strep A infection treatment; Hema-Screen Lab Pack for detection of colorectal cancer; PrimeStore MTM, a molecular transport medium that preserves and stabilizes DNA and RNA; Uri-Trak 120M urine analyzer; and clinical chemistry reagents, controls, and standards. Additionally, the company provides precision fermentation, custom bioprocessing, and contract manufacturing solutions; and diagnostic enzymes that include arylacylamidase, beta-hydroxybutyrate dehydrogenase, and salicylate hydroxylase. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.